$3.06
0.0451.50%
Last update: Nov 14, 1:42 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tharimmune (THAR) stock?
You can purchase shares of Tharimmune (NASDAQ:THAR) through any online brokerage.
Who are Tharimmune (THAR) competitors?
Other companies in Tharimmune’s space includes: Macrogenics (NASDAQ:MGNX), Kalaris Therapeutics (NASDAQ:KLRS), Adverum Biotechnologies (NASDAQ:ADVM), Gain Therapeutics (NASDAQ:GANX) and Zentalis Pharma (NASDAQ:ZNTL).
What is the forecast, or price target, for Tharimmune (THAR) stock?
Tharimmune has a consensus price target of $17.00.
What is the current price for Tharimmune (THAR)?
The stock price for Tharimmune (NASDAQ: THAR) is $2.98 last updated November 14, 2025 at 9:29 AM EST.
Does Tharimmune (THAR) pay a dividend?
There are no upcoming dividends for Tharimmune.
When is Tharimmune (NASDAQ:THAR) reporting earnings?
Tharimmune’s Q3 earnings are confirmed for Tuesday, November 25, 2025.
Is Tharimmune (THAR) going to split?
There is no upcoming split for Tharimmune.
What sector and industry does Tharimmune (THAR) operate in?
Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
